Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AbCellera Biologics (ABCL)
NASDAQ:ABCL
AbCellera Biologics (ABCL) Ownership - Who Owns AbCellera Biologics?
1,333 Followers
AbCellera Biologics (ABCL) Ownership Overview
47.45% Insiders
4.47% Mutual Funds
9.43% Other Institutional Investors
38.65% Public Companies and Individual Investors
The ownership structure of AbCellera Biologics (ABCL) stock is a mix of institutional, retail and individual investors. Approximately 13.90% of the company’s stock is owned by Institutional Investors, 47.45% is owned by Insiders and 38.65% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 27, 2024 | Carl L. G. Hansen Ceo,director, >10% Owner | Bought | $151538 |
| Nov 27, 2023 | Carl L. G. Hansen Ceo,director, >10% Owner | Bought | $151538 |
| Nov 08, 2023 | John S. Montalbano Director | Bought | $137400 |
| Sep 26, 2023 | Michael R. Hayden Director | Bought | $98200 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Sold | $429146 | |
| Dec 31, 2023 | Bought | $130814689 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 22,909,753 | Institution | 7.79% | 92,326,305 | |
| 5,480,000 | Institution | 1.86% | 22,084,400 | |
| 2,589,785 | Institution | 0.88% | 10,436,834 | |
| 1,938,013 | Institution | 0.66% | 7,810,192 | |
| 835,455 | Institution | 0.28% | 3,366,884 | |
| 747,114 | Institution | 0.25% | 3,010,869 | |
| 659,750 | Institution | 0.22% | 2,658,793 | |
| 606,663 | Institution | 0.21% | 2,444,852 | |
| 531,175 | Institution | 0.18% | 2,140,635 | |
| 477,516 | Institution | 0.16% | 1,924,389 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,480,000 | Institution | 1.86% | 22,084,400 | |
| 1,938,013 | Institution | 0.66% | 7,810,192 | |
| 835,455 | Institution | 0.28% | 3,366,884 | |
| 747,114 | Institution | 0.25% | 3,010,869 | |
| 606,663 | Institution | 0.21% | 2,444,852 | |
| 531,175 | Institution | 0.18% | 2,140,635 | |
| 477,516 | Institution | 0.16% | 1,924,389 | |
| 472,389 | Institution | 0.16% | 1,903,728 | |
| 404,211 | Institution | 0.14% | 1,628,970 | |
| 329,656 | Institution | 0.11% | 1,328,514 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,495,907 | Institution | 0.51% | 6,028,505 | |
| 340,619 | Institution | 0.12% | 1,311,383 | |
| 178,557 | Institution | 0.06% | 940,252 | |
| 155,725 | Institution | 0.05% | 599,541 | |
| 151,887 | Institution | 0.05% | 584,765 | |
| 134,918 | Institution | 0.05% | 543,720 | |
| 139,336 | Institution | 0.05% | 536,444 | |
| 106,933 | Institution | 0.04% | 411,692 | |
| 89,716 | Institution | 0.03% | 406,413 | |
| 64,811 | Institution | 0.02% | 249,522 |
FAQ
Who Owns AbCellera Biologics (ABCL)?
According to the latest TipRanks data, approximately 9.43% of the company's stock is held by institutional investors, 47.45% is held by insiders, and 38.65% is held by retail investors.
What percentage of AbCellera Biologics (ABCL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.43% of AbCellera Biologics (ABCL) stock is held by institutional investors.
What percentage of AbCellera Biologics (ABCL) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.65% of AbCellera Biologics (ABCL) stock is held by retail investors.
Who owns the most shares of AbCellera Biologics (ABCL)?
Felix Baker owns the most shares of AbCellera Biologics (ABCL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.